Journal article
Impact of pre-adapted HIV transmission
Nature Medicine, Vol.22(6), pp.606-613
2016
Abstract
Human leukocyte antigen class I (HLA)-restricted CD8(+) T lymphocyte (CTL) responses are crucial to HIV-1 control. Although HIV can evade these responses, the longer-term impact of viral escape mutants remains unclear, as these variants can also reduce intrinsic viral fitness. To address this, we here developed a metric to determine the degree of HIV adaptation to an HLA profile. We demonstrate that transmission of viruses that are pre-adapted to the HLA molecules expressed in the recipient is associated with impaired immunogenicity, elevated viral load and accelerated CD4(+) T cell decline. Furthermore, the extent of pre-adaptation among circulating viruses explains much of the variation in outcomes attributed to the expression of certain HLA alleles. Thus, viral pre-adaptation exploits 'holes' in the immune response. Accounting for these holes may be key for vaccine strategies seeking to elicit functional responses from viral variants, and to HIV cure strategies that require broad CTL responses to achieve successful eradication of HIV reservoirs.
Details
- Title
- Impact of pre-adapted HIV transmission
- Authors/Creators
- J.M. Carlson (Author/Creator) - Microsoft (United States)V.Y. Du (Author/Creator) - University of Alabama at BirminghamN. Pfeifer (Author/Creator) - Max Planck SocietyA. Bansal (Author/Creator)V.Y.F. Tan (Author/Creator) - Microsoft (United States)K. Power (Author/Creator) - Ragon Institute of MGH, MIT and HarvardC.J. Brumme (Author/Creator) - AIDS VancouverA. Kreimer (Author/Creator) - Microsoft (United States)C.E DeZiel (Author/Creator) - Microsoft (United States)N. Fusi (Author/Creator) - Microsoft (United States)M. Schaefer (Author/Creator) - Yerkes National Primate Research CenterM.A. Brockman (Author/Creator) - AIDS VancouverJ. Gilmour (Author/Creator) - Imperial College LondonM.A. Price (Author/Creator) - University of California, San FranciscoW. Kilembe (Author/Creator) - Rwanda Zambia HIV Research GroupR. Haubrich (Author/Creator) - Gilead Sciences (United States)M. John (Author/Creator) - Royal Perth HospitalS. Mallal (Author/Creator) - Vanderbilt UniversityR. Shapiro (Author/Creator) - Harvard UniversityJ. Frater (Author/Creator) - University of OxfordP.R. Harrigan (Author/Creator) - University of British ColumbiaT. Ndung'u (Author/Creator) - Max Planck SocietyS. Allen (Author/Creator) - Rwanda Zambia HIV Research GroupD. Heckerman (Author/Creator) - Microsoft (Canada)J. Sidney (Author/Creator) - La Jolla Institute for ImmunologyT.M. Allen (Author/Creator) - Ragon Institute of MGH, MIT and HarvardP.J.R. Goulder (Author/Creator) - University of OxfordZ.L. Brumme (Author/Creator) - AIDS VancouverE. Hunter (Author/Creator) - Rwanda Zambia HIV Research GroupP.A. Goepfert (Author/Creator) - University of Alabama at Birmingham
- Publication Details
- Nature Medicine, Vol.22(6), pp.606-613
- Publisher
- Nature Publishing Group
- Identifiers
- 991005542570407891
- Copyright
- © 2016 Macmillan Publishers Limited
- Murdoch Affiliation
- Institute for Immunology and Infectious Diseases
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Metrics
63 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Industry collaboration
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.66 HIV
- 1.66.46 HIV Pathogenesis
- Web Of Science research areas
- Biochemistry & Molecular Biology
- Cell Biology
- Medicine, Research & Experimental
- ESI research areas
- Molecular Biology & Genetics